Aris Sterodimas

Dr. Aris Sterodimas

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2009 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
YIYves Gérard Illouz
Yves Gérard Illouz
ASAris Sterodimas
Aris Sterodimas

1 August 2011 in Aesthetic Surgery Journal
Verified
Journal Article
Closed access
ASAris Sterodimas
Aris Sterodimas
JFJose de Faria
Jose de Faria
BNBeatriz Nicaretta
Beatriz Nicaretta
FBFilippo Boriani
Filippo Boriani
Several techniques for lipoinjection have been described in the literature. Recently, the role of adult stem cells in adipose tissue has gained interest. The authors compare autologous fat transplantation to adipose-derived stem cell-enriched lipografts. A group of 20 patients with congenital or acquired facial tissue defects were included in this study and randomly divided into two groups. Ten patients were treated with autologous fat transplantation (Group A; 12-165 mL per session), and the remaining ten were treated with adipose-derived stem cell-enriched lipografts (Group B; 8-155 mL per session). Overall patient satisfaction after both treatments was evaluated at six, 12, and 18 months after the initial surgical procedure. In Group A, three patients achieved aesthetically-acceptable results after the first treatment; the remaining seven patients required additional sessions. In Group B, all patients required only one treatment. Analysis of patient satisfaction in the first six months clearly demonstrated better results in Group B. However, by the 18-month evaluation, there was no statistical difference between the two groups in terms of patient satisfaction. Adipose-derived stem cell-enriched lipografts produced aesthetically-acceptable results without the need for repeat treatment sessions, which are necessary with autologous fat transplantation. Further long-term studies are necessary to confirm the favorable results seen in this study.

Verified
Journal Article
Open access
PDF file
Pietro GentilePietro Gentile
Pietro Gentile
ASAris Sterodimas
Aris Sterodimas
JPJacopo Pizzicannella
Jacopo Pizzicannella
LDLaura Dionisi
Laura Dionisi
DFDomenico De Fazio
Domenico De Fazio
SGSimone Garcovich
Simone Garcovich
Stromal vascular fraction (SVF) containing adipose stem cells (ASCs) has been used for many years in regenerative plastic surgery for autologous applications, without any focus on their potential allogenic role. Allogenic SVF transplants could be based on the possibility to use decellularized extracellular matrix (ECM) as a scaffold from a donor then re-cellularized by ASCs of the recipient, in order to develop the advanced therapy medicinal products (ATMP) in fully personalized clinical approaches. A systematic review of this field has been realized in accordance with the Preferred Reporting for Items for Systematic Reviews and Meta-Analyses-Protocols (PRISMA-P) guidelines. Multistep research of the PubMed, Embase, MEDLINE, Pre-MEDLINE, PsycINFO, CINAHL, Clinicaltrials.gov, Scopus database, and Cochrane databases has been conducted to identify articles and investigations on human allogenic ASCs transplant for clinical use. Of the 341 articles identified, 313 were initially assessed for eligibility on the basis of the Of these, only 29 met all the predetermined criteria for inclusion according to the PICOS (patients, intervention, comparator, outcomes, and study design) approach, and 19 have been included in quantitative synthesis (meta-analysis). Ninety-one percent of the studies previously screened (284 papers) were focused on the in vitro results and pre-clinical experiments. The allogenic use regarded the treatment of perianal fistulas, diabetic foot ulcers, knee osteoarthritis, acute respiratory distress syndrome, refractory rheumatoid arthritis, pediatrics disease, fecal incontinence, ischemic heart disease, autoimmune encephalomyelitis, lateral epicondylitis, and soft tissue defects. The information analyzed suggested the safety and efficacy of allogenic ASCs and ECM transplants without major side effects.

1 January 2010 in Aesthetic Surgery Journal
Verified
Journal Article
Open access
PDF file
ASAris Sterodimas
Aris Sterodimas
JFJose de Faria
Jose de Faria
BNBeatriz Nicaretta
Beatriz Nicaretta
OPOthonas Papadopoulos
Othonas Papadopoulos
EPEfstathios Papalambros
Efstathios Papalambros
YIYves Gérard Illouz
Yves Gérard Illouz
Adipose tissue is believed to constitute an ideal source of uncultured stromal stem cells. By optimizing the harvesting, storage, and transplantation

1 April 2009 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
ASAris Sterodimas
Aris Sterodimas
JFJose de Faria
Jose de Faria
WCWanda Elizabeth Correa
Wanda Elizabeth Correa
IPIvo Pitanguy
Ivo Pitanguy

1 November 2009 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
ASAris Sterodimas
Aris Sterodimas
JHJulio Cesar Huanquipaco
Julio Cesar Huanquipaco
SFSinezio de Souza Filho
Sinezio de Souza Filho
FBFabio Antonio Bornia
Fabio Antonio Bornia
IPIvo Pitanguy
Ivo Pitanguy